While some studies suggest SIRT6 acts as a tumour promoter by preventing DNA damage and cellular senescence [205], others indicate that it suppresses tumour growth by inhibiting the ERK1/2 pathway [206]. The gene discussed is MAPK3; the disease is neoplasm.